BRAF Targeting Across Solid Tumors: Molecular Aspects and Clinical Applications.

Int J Mol Sci · 2025 · PMC12027668 · PMID 40332392

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[ 149 ], melanomas with baseline loss or mutations of PTEN showed a trend toward shorter median progression-free survival compared to those with normal PTEN expression.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.